Date published: 2026-5-18

1-800-457-3801

SCBT Portrait Logo
Seach Input

C3orf59 Inhibitors

C3orf59 inhibitors would be a class of compounds designed to selectively bind to and inhibit the function of the protein produced by the C3orf59 gene, where "C3orf59" stands for "chromosome 3 open reading frame 59." This nomenclature typically indicates that the gene is located on chromosome 3 and has been sequenced, but its function may not be fully characterized. Proteins encoded by genes with 'orf' in their names often have less well-understood biological roles. The protein product of C3orf59 may be involved in a particular cellular process, and inhibiting this protein could potentially affect that process. The inhibitors themselves would be small molecules or other suitable chemical entities that demonstrate specificity toward the C3orf59 protein, binding to it in a manner that alters its natural activity within the cell.

The initial development of C3orf59 inhibitors would likely involve a combination of computational and experimental techniques aimed at understanding the protein's structure and function. If the three-dimensional structure of the C3orf59 protein were available, it would greatly facilitate the design of inhibitory molecules by highlighting potential binding sites and conformational dynamics. Techniques such as X-ray crystallography, NMR spectroscopy, or cryo-electron microscopy might be employed to resolve the structure. In the absence of direct structural data, predictive models based on related protein structures could guide the inhibitor design process. Alongside structural considerations, functional studies would be vital to identify the role of C3orf59 in cellular physiology, such as its involvement in signaling pathways, gene expression regulation, or cellular metabolism. This information would help clarify which aspects of the protein's function are most amenable to inhibition.

SEE ALSO...

Items 1 to 10 of 12 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

5-Azacytidine

320-67-2sc-221003
500 mg
$280.00
4
(1)

This compound can inhibit DNA methyltransferase, potentially causing DNA demethylation and altering the expression of genes like MAB21L2.

Suberoylanilide Hydroxamic Acid

149647-78-9sc-220139
sc-220139A
100 mg
500 mg
$133.00
$275.00
37
(2)

A histone deacetylase inhibitor that can affect chromatin structure and gene expression, possibly including MAB21L2.

Trichostatin A

58880-19-6sc-3511
sc-3511A
sc-3511B
sc-3511C
sc-3511D
1 mg
5 mg
10 mg
25 mg
50 mg
$152.00
$479.00
$632.00
$1223.00
$2132.00
33
(3)

Another histone deacetylase inhibitor, it may change the expression pattern of genes, potentially impacting MAB21L2 expression.

Mithramycin A

18378-89-7sc-200909
1 mg
$55.00
6
(1)

It binds to DNA and can interfere with transcription factor binding, possibly affecting MAB21L2 gene transcription.

Actinomycin D

50-76-0sc-200906
sc-200906A
sc-200906B
sc-200906C
sc-200906D
5 mg
25 mg
100 mg
1 g
10 g
$74.00
$243.00
$731.00
$2572.00
$21848.00
53
(3)

This antibiotic intercalates into DNA, inhibiting RNA polymerase and potentially decreasing MAB21L2 gene transcription.

Rapamycin

53123-88-9sc-3504
sc-3504A
sc-3504B
1 mg
5 mg
25 mg
$63.00
$158.00
$326.00
233
(4)

As an mTOR inhibitor, it might reduce protein synthesis in general, which could affect the expression of MAB21L2.

LY 294002

154447-36-6sc-201426
sc-201426A
5 mg
25 mg
$123.00
$400.00
148
(1)

Inhibiting PI3K can disrupt downstream signaling pathways that regulate gene expression, potentially impacting MAB21L2.

PD 98059

167869-21-8sc-3532
sc-3532A
1 mg
5 mg
$40.00
$92.00
212
(2)

This MEK inhibitor may affect the MAPK/ERK pathway and influence the transcription of various genes including MAB21L2.

5-Aza-2′-Deoxycytidine

2353-33-5sc-202424
sc-202424A
sc-202424B
25 mg
100 mg
250 mg
$218.00
$322.00
$426.00
7
(1)

Like 5-Azacytidine, it may cause DNA hypomethylation and alter gene expression profiles, including that of MAB21L2.

Bortezomib

179324-69-7sc-217785
sc-217785A
2.5 mg
25 mg
$135.00
$1085.00
115
(2)

This proteasome inhibitor might affect protein turnover, including transcription factors that regulate MAB21L2 expression.